Literature DB >> 23704223

Refusing treatment.

Moshe Frenkel1.   

Abstract

Keywords:  Alternative medicine; Cancer care; Complementary medicine; Declining cancer treatment; Patient-doctor communication; Refusing treatment

Mesh：

Year:  2013        PMID： 23704223      PMCID： PMC3662856          DOI： 10.1634/theoncologist.2012-0436

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  19 in total

1.  The quality of life of cancer patients who refuse chemotherapy.

Authors:  O Gilbar
Journal:  Soc Sci Med       Date:  1991       Impact factor: 4.634

2.  Causes for the undertreatment of elderly breast cancer patients: tailoring treatments to individual patients.

Authors:  Vic Velanovich; Molly Gabel; Eleanor M Walker; Thomas J Doyle; Robert M O'Bryan; Wanda Szymanski; John J Ferrara; Frank R Lewis
Journal:  J Am Coll Surg       Date:  2002-01       Impact factor: 6.113

Review 3.  Communication in cancer care: discussing complementary and alternative medicine.

Authors:  Moshe Frenkel; Eran Ben-Arye; Lorenzo Cohen
Journal:  Integr Cancer Ther       Date:  2010-03-31       Impact factor: 3.279

4.  Why some cancer patients choose complementary and alternative medicine instead of conventional treatment.

Authors:  D M Shumay; G Maskarinec; H Kakai; C C Gotay
Journal:  J Fam Pract       Date:  2001-12       Impact factor: 0.493

5.  Patient compliance is critical for equivalent clinical outcomes for breast cancer treated by breast-conservation therapy.

Authors:  B D Li; W A Brown; F L Ampil; G V Burton; H Yu; J C McDonald
Journal:  Ann Surg       Date:  2000-06       Impact factor: 12.969

6.  Factors associated with acceptance or rejection of recommendation for chemotherapy in a community cancer center.

Authors:  M Levin; H Mermelstein; C Rigberg
Journal:  Cancer Nurs       Date:  1999-06       Impact factor: 2.592

7.  Patients who refuse treatment in medical hospitals.

Authors:  P S Appelbaum; L H Roth
Journal:  JAMA       Date:  1983-09-09       Impact factor: 56.272

8.  Systematic understanding of cancer patients who refuse treatment.

Authors:  R J Goldberg
Journal:  Psychother Psychosom       Date:  1983       Impact factor: 17.659

9.  Telling their stories, telling our stories: physicians' experiences with patients who decide to forgo or stop treatment for cancer.

Authors:  Irena Madjar; Lea Kacen; Samuel Ariad; Jim Denham
Journal:  Qual Health Res       Date:  2007-04

10.  Declining conventional cancer treatment and using complementary and alternative medicine: a problem or a challenge?

Authors:  M J Verhoef; M S Rose; M White; L G Balneaves
Journal:  Curr Oncol       Date:  2008-08       Impact factor: 3.677
View more
  8 in total

1.  Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.

Authors:  Kendra L Schwartz; Michael S Simon; Lauren C Bylsma; Julie J Ruterbusch; Jennifer L Beebe-Dimmer; Neil M Schultz; Scott C Flanders; Arie Barlev; Jon P Fryzek; Ruben G W Quek
Journal:  Cancer       Date:  2018-03-05       Impact factor: 6.860

Review 2.  Systematic review of the predictors of health service use in pancreatic cancer.

Authors:  Nadia N Khan; Tennille Lewin; Amy Hatton; Charles Pilgrim; Liane Ioannou; Luc Te Marvelde; John Zalcberg; Sue Evans
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

3.  Impact of the third national 'Be Clear on Cancer' Breast Cancer in Women over 70 Campaign on general practitioner attendance and referral, diagnosis rates and prevalence awareness.

Authors:  Judith Eberhardt; Chloe J Bright; Carolyn Gildea; Osa Adeghe; Vivian Mak; Lizz Paley; Jonathan Ling; Lucy Elliss-Brookes
Journal:  Eur J Cancer Care (Engl)       Date:  2022-04-05       Impact factor: 2.328

4.  Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis.

Authors:  Rosa A van Amerongen; Valesca P Retèl; Veerle Mh Coupé; Petra M Nederlof; Maartje J Vogel; Wim H van Harten
Journal:  Ecancermedicalscience       Date:  2016-10-28

Review 5.  Abiraterone acetate and prednisone in chemotherapy-naïve prostate cancer patients: rationale, evidence and clinical utility.

Authors:  E David Crawford; Neal D Shore; Daniel P Petrylak; Celestia S Higano; Charles J Ryan
Journal:  Ther Adv Med Oncol       Date:  2017-03-22       Impact factor: 8.168

6.  "I Made All Decisions Myself": Breast Cancer Treatment Decision-Making by Receivers and Decliners.

Authors:  Eunjung Kim; Sou Hyun Jang; M Robyn Andersen; Leanna J Standish
Journal:  Asia Pac J Oncol Nurs       Date:  2021-03-26

7.  First-Line Pharmacotherapies and Survival among Patients Diagnosed with Non-Resectable NSCLC: A Real-Life Setting Study with Gender Prospective.

Authors:  Andrea Spini; Rosa Gini; Pietro Rosellini; Allison Singier; Cristiana Bellan; Alessandra Pascucci; Lorenzo Leoncini; Clément Mathieu; Ignazio Martellucci; Folco Furiesi; Silvano Giorgi; Sandra Donnini; Giuseppe Roberto; Marina Ziche; Francesco Salvo
Journal:  Cancers (Basel)       Date:  2021-12-05       Impact factor: 6.639

Review 8.  Cancer resistance to treatment and antiresistance tools offered by multimodal multifunctional nanoparticles.

Authors:  Eudald Casals; Muriel F Gusta; Macarena Cobaleda-Siles; Ana Garcia-Sanz; Victor F Puntes
Journal:  Cancer Nanotechnol       Date:  2017-10-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.